Literature DB >> 12690190

Developing a platform for genomic medicine in Mexico.

Gerardo Jimenez-Sanchez1.   

Abstract

Mexico is preparing to develop a genomic medicine program focused on national health problems. Modern Mexicans result from an admixture of more than 65 native Indian groups with Spaniards, leading to a unique genetic makeup and a characteristic set of disease susceptibilities. Since 1999, more than 100 experts from different fields have joined efforts with government, academia, and industry to identify priorities and goals for genomic medicine in Mexico. The plan includes establishment of an Institute of Genomic Medicine with strong intramural and extramural programs. This project is expected to ease the social and financial burden of health problems in Mexico.

Mesh:

Year:  2003        PMID: 12690190     DOI: 10.1126/science.1084059

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico.

Authors:  Irma Silva-Zolezzi; Alfredo Hidalgo-Miranda; Jesus Estrada-Gil; Juan Carlos Fernandez-Lopez; Laura Uribe-Figueroa; Alejandra Contreras; Eros Balam-Ortiz; Laura del Bosque-Plata; David Velazquez-Fernandez; Cesar Lara; Rodrigo Goya; Enrique Hernandez-Lemus; Carlos Davila; Eduardo Barrientos; Santiago March; Gerardo Jimenez-Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

2.  Confidentiality and data sharing: vulnerabilities of the Mexican Genomics Sovereignty Act.

Authors:  Augusto Rojas-Martínez
Journal:  J Community Genet       Date:  2015-05-20

3.  Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.

Authors:  Ritu Kumari; Ram Lakhan; R K Garg; J Kalita; U K Misra; Balraj Mittal
Journal:  Indian J Hum Genet       Date:  2011-05

4.  Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients.

Authors:  Adiel Ortega-Ayala; Nidia Samara Rodríguez-Rivera; Fernando de Andrés; Adrián LLerena; Eliseo Pérez-Silva; Adriana Guadalupe Espinosa-Sánchez; Juan Arcadio Molina-Guarneros
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-22

Review 5.  Development of genomic sciences in Mexico: a good start and a long way to go.

Authors:  Rafael Palacios; Julio Collado-Vides
Journal:  PLoS Comput Biol       Date:  2007-09       Impact factor: 4.475

6.  External validation of the relative fat mass (RFM) index in adults from north-west Mexico using different reference methods.

Authors:  Alan E Guzmán-León; Ana G Velarde; Milca Vidal-Salas; Lucía G Urquijo-Ruiz; Luz A Caraveo-Gutiérrez; Mauro E Valencia
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

7.  A Bibliometric Analysis of Mexican Bioinformatics: A Portrait of Actors, Structure, and Dynamics.

Authors:  Dagoberto Armenta-Medina; Christian Díaz de León Castañeda; Alma Armenta-Medina; Ernesto Perez-Rueda
Journal:  Biology (Basel)       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.